Direkt zum Inhalt
Merck
  • Anti-glioma Natural Products Downregulating Tumor Glycolytic Enzymes from Marine Actinomycete Streptomyces sp. ZZ406.

Anti-glioma Natural Products Downregulating Tumor Glycolytic Enzymes from Marine Actinomycete Streptomyces sp. ZZ406.

Scientific reports (2018-01-10)
Mengxuan Chen, Weiyun Chai, Tengfei Song, Mingzhu Ma, Xiao-Yuan Lian, Zhizhen Zhang
ZUSAMMENFASSUNG

Marine natural products are important resources for discovering novel anticancer drugs. In this study, an extract prepared from the culture of a sea anemone-derived actinomycete Streptomyces sp. ZZ406 in soluble starch and casein-related liquid medium was found to have activity in inhibiting the proliferation of glioma cells and reducing the production of lactate in glioma cells. Chemical investigation of this active crude extract resulted in the isolation of four new compounds and seven known ones. Structures of the new compounds were determined by a combination of extensive NMR analyses, HRESIMS and MS-MS data, electronic circular dichroism calculation, chemical degradation, and Marfey's method. New compound 1 showed potent activity against the proliferation of different glioma cells with IC

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
D-Leucin, ReagentPlus®, 99%
Supelco
Nα-(2,4-Dinitro-5-fluorophenyl)-L-alaninamid, for chiral derivatization, LiChropur, ≥99.0%